Abstract
Increased numbers of tumor-infiltrating lymphocytes (TILs) in high-grade serous ovarian cancer (HGSC) are associated with improved clinical outcome. Intraepithelial localization of TILs might be regulated by specific homing receptors, such as CD103, which is widely expressed by intraepithelial lymphocytes. Given the emerging role of CD103 TILs, we aimed to assess their contribution to the prognostic value of immunoscoring in HGSC. The density of intratumoral CD3 and CD103 lymphocytes was examined by immunohistochemistry on a tissue microarray of a series of 135 patients with advanced HGSC and correlated with CD4, CD8, CD56, FoxP3, and TCRγ T-cell counts, as well as E-cadherin staining and conventional prognostic parameters and clinical outcome. Both the presence of CD103 cells, as well as high numbers of intraepithelial CD3 lymphocytes (CD3E), showed a significant correlation with overall survival, in the complete series, as well as in patients with optimal debulking and/or platinum sensitivity. Combining CD3 and CD103 counts improved prognostication and identified 3 major subgroups with respect to overall survival. The most pronounced effect was demonstrated for patients with optimally resected and platinum-sensitive tumors. P...Continue Reading
References
Jan 17, 2003·The New England Journal of Medicine·Lin ZhangGeorge Coukos
Apr 17, 2004·The American Journal of Surgical Pathology·Anais MalpicaElvio G Silva
Dec 14, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eiichi SatoKunle Odunsi
Feb 22, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Khoon-Lin LingVincenzo Cerundolo
Apr 17, 2007·Gynecologic Oncology·A BamiasM A Dimopoulos
Nov 27, 2007·Gynecologic Oncology·Markéta TomsováIvo Steiner
Dec 7, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Taimei YangBrad H Nelson
Dec 9, 2008·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Blaise ClarkeC Blake Gilks
May 28, 2009·Cancer·Sarah F AdamsGeorge Coukos
Jul 30, 2009·Cancer Research·Katarzyna FranciszkiewiczFathia Mami-Chouaib
Jul 31, 2009·PloS One·Katy MilneBrad H Nelson
Oct 29, 2009·British Journal of Cancer·M StumpfS Lassmann
Dec 17, 2009·Gynecologic Oncology·Jason C BarnettAndrew Berchuck
Dec 22, 2009·Pathology Oncology Research : POR·Ahmad Al-AttarStephen Chan
Jun 15, 2010·Gynecologic Oncology·John R WebbBrad H Nelson
Sep 9, 2010·International Journal of Cancer. Journal International Du Cancer·Guillaume SarrabayrouseFrancine Jotereau
Dec 15, 2010·International Journal of Cancer. Journal International Du Cancer·Desheng WengJianlin Gong
May 10, 2011·The Journal of Immunology : Official Journal of the American Association of Immunologists·James KrempskiKeith L Knutson
Jun 2, 2011·British Journal of Cancer·M J M GoodenH W Nijman
Nov 2, 2011·Gynecologic Oncology·Wei-Ting HwangGeorge Coukos
Nov 29, 2011·Cancer Immunology, Immunotherapy : CII·Dongmei LaiLihe Guo
Mar 1, 2012·Journal of Translational Medicine·Katy MilneBrad H Nelson
Sep 13, 2013·The Journal of Pathology·Ryan O EmersonHarlan S Robins
Sep 21, 2013·BMC Cancer·Anna Bachmayr-HeydaDan Cacsire Castillo-Tong
Oct 29, 2013·Nature Immunology·Laura K MackayThomas Gebhardt
Nov 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John R WebbBrad H Nelson
Nov 19, 2013·PloS One·Claudia C PrestonKeith L Knutson
Dec 7, 2013·Science Translational Medicine·Harlan S RobinsJason H Bielas
Aug 8, 2014·Oncoimmunology·John R WebbBrad H Nelson
May 10, 2015·Cancer Immunology Research·John R WebbBrad H Nelson
Citations
Jun 21, 2016·Journal de gynécologie, obstétrique et biologie de la reproduction·M NayamaD Vinatier
Dec 17, 2016·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Hans-Christian BösmüllerAnnette Staebler
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Briana G Nixon, Ming O Li
Jul 15, 2018·Histopathology·Silvia Darb-EsfahaniElena I Braicu
Aug 5, 2017·Advances in Anatomic Pathology·Shona HendryStephen B Fox
Jun 29, 2017·Oncotarget·Moritz JesinghausMelanie Boxberg
Feb 6, 2017·Oncotarget·Jun LiXin Lu
Sep 22, 2016·Oncotarget·Fenne L KomdeurMarco de Bruyn
Jun 1, 2020·Journal for Immunotherapy of Cancer·John P LynesEdjah K Nduom
Aug 29, 2019·Frontiers in Immunology·Sarah NersesianJeanette E Boudreau
Jan 24, 2020·Cellular & Molecular Immunology·S C SassonL K Mackay
Sep 22, 2017·BMC Cancer·Fiona R JamesH Raza Ali
Mar 9, 2019·Scientific Reports·Younghoon KimGyeong Hoon Kang
Jul 8, 2020·Cancers·Alejandra MartinezChristel Devaud
Jun 17, 2020·The International Journal of Biological Markers·Xingxia ZhangKa Li
Aug 11, 2018·Frontiers in Immunology·Julian Smazynski, John R Webb
Jan 27, 2019·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Grzegorz SzewczykDariusz Szukiewicz
Sep 28, 2018·Frontiers in Immunology·Nina DumauthiozPedro Romero
Aug 15, 2018·Cancers·Nkechiyere G NwaniDaniela Matei
Jun 20, 2020·Journal of Leukocyte Biology·Sohini RoyDouglas B Johnson
Jun 9, 2016·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhi-Qiang WangPeter H Watson
Jul 1, 2019·Trends in Immunology·Simone L ParkLaura K Mackay
Dec 18, 2020·Translational Oncology·Yılmaz BaşHavva Hande Keser Şahin
Jan 22, 2021·Seminars in Cancer Biology·Alia GhoneumNeveen Said
Nov 17, 2020·Therapeutic Advances in Medical Oncology·Jiatao HaoYan Xue
Mar 24, 2021·The Journal of Experimental Medicine·Karolina OkłaWeiping Zou
Mar 23, 2021·Frontiers in Oncology·Nicole E JamesJennifer R Ribeiro
Apr 11, 2021·European Journal of Immunology·Klaas P J M van GisbergenChristian Münz
Aug 3, 2021·Frontiers in Immunology·Eric de SousaMarkus Maeurer
Mar 24, 2021·Cold Spring Harbor Perspectives in Biology·Simone L Park, Laura K Mackay